175 related articles for article (PubMed ID: 19036501)
1. Genetic polymorphisms of transforming growth factor-beta1 and its receptors and colorectal cancer susceptibility: a population-based case-control study in China.
Zhang Y; Liu B; Jin M; Ni Q; Liang X; Ma X; Yao K; Li Q; Chen K
Cancer Lett; 2009 Mar; 275(1):102-8. PubMed ID: 19036501
[TBL] [Abstract][Full Text] [Related]
2. Correlation of transforming growth factor beta-1 gene polymorphisms C-509T and T869C and the risk of gastric cancer in China.
Li T; Cao BW; Dai Y; Cui H; Yang HL; Xu CQ
J Gastroenterol Hepatol; 2008 Apr; 23(4):638-42. PubMed ID: 18341540
[TBL] [Abstract][Full Text] [Related]
3. Association of transforming growth factor-beta1 gene polymorphisms with genetic susceptibility to nasopharyngeal carcinoma.
Wei YS; Zhu YH; Du B; Yang ZH; Liang WB; Lv ML; Kuang XH; Tai SH; Zhao Y; Zhang L
Clin Chim Acta; 2007 May; 380(1-2):165-9. PubMed ID: 17368597
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of transforming growth factor-β1 associated with increased risk of gastric cardia adenocarcinoma in north China.
Guo W; Dong Z; Guo Y; Chen Z; Yang Z; Kuang G; Shan B
Int J Immunogenet; 2011 Jun; 38(3):215-24. PubMed ID: 21205231
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
Shin A; Shu XO; Cai Q; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1567-70. PubMed ID: 15941974
[TBL] [Abstract][Full Text] [Related]
7. Analysis of common transforming growth factor beta-1 gene polymorphisms in gastric and duodenal ulcer disease: pilot study.
Polonikov AV; Ivanov VP; Belugin DA; Khoroshaya IV; Kolchanova IO; Solodilova MA; Tutochkina MP; Stepchenko AA
J Gastroenterol Hepatol; 2007 Apr; 22(4):555-64. PubMed ID: 17376051
[TBL] [Abstract][Full Text] [Related]
8. Regulatory cytokine gene polymorphisms and risk of colorectal carcinoma.
Crivello A; Giacalone A; Vaglica M; Scola L; Forte GI; Macaluso MC; Raimondi C; Di Noto L; Bongiovanni A; Accardo A; Candore G; Palmeri L; Verna R; Caruso C; Lio D; Palmeri S
Ann N Y Acad Sci; 2006 Nov; 1089():98-103. PubMed ID: 17261758
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer.
Amirghofran Z; Jalali SA; Ghaderi A; Hosseini SV
Cancer Genet Cytogenet; 2009 Apr; 190(1):21-5. PubMed ID: 19264229
[TBL] [Abstract][Full Text] [Related]
10. Genetic variation in transforming growth factor-beta1 gene associated with increased risk of esophageal squamous cell carcinoma.
Wei YS; Xu QQ; Wang CF; Pan Y; Liang F; Long XK
Tissue Antigens; 2007 Dec; 70(6):464-9. PubMed ID: 17990985
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression.
Försti A; Li X; Wagner K; Tavelin B; Enquist K; Palmqvist R; Altieri A; Hallmans G; Hemminki K; Lenner P
Genes Chromosomes Cancer; 2010 Mar; 49(3):270-81. PubMed ID: 19998449
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-[beta]1 -509T reduces risk of colorectal cancer, but not adenoma in Koreans.
Chung SJ; Kim JS; Jung HC; Song IS
Cancer Sci; 2007 Mar; 98(3):401-4. PubMed ID: 17214746
[TBL] [Abstract][Full Text] [Related]
13. Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy.
Carturan S; Roccatello D; Menegatti E; Di Simone D; Davit A; Piazza A; Sena LM; Matullo G
J Nephrol; 2004; 17(6):786-93. PubMed ID: 15593052
[TBL] [Abstract][Full Text] [Related]
14. [Effect of polymorphism of transforming growth factor beta1 gene on HBV-induced liver cirrhosis].
Yang ZX; Wang H; Gao CF; Xu LL; Zhao WJ
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(15):1021-6. PubMed ID: 16029542
[TBL] [Abstract][Full Text] [Related]
15. Associations between gout tophus and polymorphisms 869T/C and -509C/T in transforming growth factor beta1 gene.
Chang SJ; Chen CJ; Tsai FC; Lai HM; Tsai PC; Tsai MH; Ko YC
Rheumatology (Oxford); 2008 May; 47(5):617-21. PubMed ID: 18356176
[TBL] [Abstract][Full Text] [Related]
16. Start codon polymorphisms in the vitamin D receptor and colorectal cancer risk.
Park K; Woo M; Nam J; Kim JC
Cancer Lett; 2006 Jun; 237(2):199-206. PubMed ID: 16019132
[TBL] [Abstract][Full Text] [Related]
17. TGFbeta1 polymorphism (L10P) and risk of colorectal adenomatous and hyperplastic polyps.
Sparks R; Bigler J; Sibert JG; Potter JD; Yasui Y; Ulrich CM
Int J Epidemiol; 2004 Oct; 33(5):955-61. PubMed ID: 15020570
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk.
Lee KM; Park SK; Hamajima N; Tajima K; Yoo KY; Shin A; Noh DY; Ahn SH; Hirvonen A; Kang D
Breast Cancer Res Treat; 2005 Mar; 90(2):149-55. PubMed ID: 15803361
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility of epidermal growth factor +61A>G and transforming growth factor beta1 -509C>T gene polymorphisms with gallbladder cancer.
Vishnoi M; Pandey SN; Modi DR; Kumar A; Mittal B
Hum Immunol; 2008 Jun; 69(6):360-7. PubMed ID: 18571008
[TBL] [Abstract][Full Text] [Related]
20. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
